Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Chemomab Therapeutics Ltd. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- 0 vs. Q2 2024
- Shares held
- 4.55M
- +1.88M (+70.2%) vs. Q2 2024
- Total value
- $7.14M
- +$4.70M (+192.6%) vs. Q2 2024
- New holders
- 6
- 4 more added
- Sold out
- 6
- 1 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMMB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $615.3K |
| Q1 2026 | 15 | $551.9K |
| Q4 2025 | 14 | $606.1K |
| Q3 2025 | 10 | $1.03M |
| Q2 2025 | 14 | $4.91M |
| Q1 2025 | 17 | $4.07M |
| Q4 2024 | 16 | $7.53M |
| Q3 2024 | 15 | $7.14M |
| Q2 2024 | 15 | $2.44M |
| Q1 2024 | 14 | $2.07M |
| Q4 2023 | 16 | $1.43M |
| Q3 2023 | 11 | $2.26M |
| Q2 2023 | 11 | $3.33M |
| Q1 2023 | 13 | $4.56M |
| Q4 2022 | 14 | $10.6M |
| Q3 2022 | 15 | $8.09M |
| Q2 2022 | 13 | $12.2M |
| Q1 2022 | 15 | $15.9M |
| Q4 2021 | 14 | $22.7M |
| Q3 2021 | 15 | $35.9M |
| Q2 2021 | 12 | $58.7M |
| Q1 2021 | 10 | $82.6M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Chemomab Therapeutics Ltd.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 1,741,273 | $2.73M | 0.05% | −500,000−22.3% | Reduced |
| Sphera Funds Management Ltd. | 1,214,575 | $1.91M | 0.31% | +1,214,575 | New |
| Yelin Lapidot Holdings Management Ltd. | 809,717 | $1.27M | 0.21% | +809,717 | New |
| Morgan Stanley | 402,272 | $631.6K | 0.00% | +395,072+5,487.1% | Added |
| Ikarian Capital, LLC | 213,392 | $335.0K | 0.10% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 39,939 | $62.7K | 0.00% | +39,939 | New |
| Kestra Private Wealth Services, LLC | 31,241 | $49.0K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 27,573 | $43.3K | 0.00% | +7,696+38.7% | Added |
| Boothbay Fund Management, LLC | 26,529 | $41.7K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 15,223 | $23.9K | 0.00% | +157+1.0% | Added |
| HRT Financial LP | 13,579 | $21.0K | 0.00% | +13,579 | New |
| Millennium Management LLC | 10,565 | $16.6K | 0.00% | +10,565 | New |
| UBS Group AG | 2,288 | $3.59K | 0.00% | +2,288 | New |
| JPMorgan Chase & Co | 1,101 | $1.73K | 0.00% | +1,100+110,000.0% | Added |
| Moser Wealth Advisors, LLC | 500 | $785 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −62,402−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −24,394−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −18,100−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −11,737−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −44−100.0% | Sold out |